Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.
June 23, 2016
Share
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd (KOSDAQ:A092730) from Ahn, Yong-Chan and 7 individuals for KRW 72.8 billion on December 7, 2015. Han Bul Cosmetics and the individual will acquire 2.08 million shares at KRW 35,000 per share. Han Bul Cosmetics and the individual will pay KRW 2 billion as deposit at the time of signing of the contract, will pay KRW 21.23 billion until December 28, 2015 and Ahn, Yong-Chan and 7 individuals will transfer 0.62 million shares and Han Bul Cosmetics and the individual will pay KRW 49.54 billion until June 30, 2016 and Ahn, Yong-Chan and 7 individuals will transfer 1.46 million shares to Han Bul Cosmetics and the individual. The transaction is expected to complete on June 30, 2016.
As of December 28, 2015, Han Bul Cosmetics Co., Ltd. and Lim, Byoung-Cheol amended the offer per share to KRW 34,690 to acquire 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan, Chae, Seung-Seok, Aekyung Co., Ltd, Admission Co., Ltd., Chae-Hyung-Seok, Chae, Eun-Jung, Ahn, Rina and Ahn, Sae-Mi for KRW 72.1 billion on December 7, 2015. Ahn, Yong-Chan, Chae, Seung-Seok, Aekyung Co., Ltd, Admission Co., Ltd., Chae-Hyung-Seok, Chae, Eun-Jung, Ahn, Rina and Ahn, Sae-Mi will sell 1 million, 0.61 million, 0.33 million, 0.04 million, 0.04 million, 0.03 million, 0.02 million and 0.02 million shares respectively. Han Bul Cosmetics and Lim, Byoung-Cheol paid KRW 2 billion as deposit on December 7, 2015, will pay KRW 21.04 billion until December 28, 2015 and will pay KRW 49.09 billion until June 30, 2016 and Ahn, Yong-Chan and 7 individuals will transfer 1.46 million shares to Han Bul Cosmetics and the individual. As of December 28, 2015, Han Bul Cosmetics and Lim, Byoung-Cheol acquired 0.39 million shares from Ahn, Yong-Chan and Han Bul Cosmetics acquired 0.24 million shares from Chae, Seung-Seok.
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd (KOSDAQ:A092730) from Ahn, Yong-Chan and 7 individuals on June 23, 2016. On June 23, 2016, Han Bul Cosmetics acquired 0.6 million shares from Yong-chan, 0.4 million shares from Seung-Seok, 0.3 million from Aekyung, 0.04 million shares from Admission Co., Ltd., 0.04 million shares from Chae-Hyung-Seok, 0.03 million shares from Eun-Jung, 0.02 million shares from Rina Ahn, 0.02 million shares from Sae-Mi and 0.05 million shares from Yoon Kim.
NeoPharm Co., Ltd. is a Korea-based company engaged in the manufacture of cosmetics. The Company produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. It also engages in the original equipment manufacturing (OEM) of skin drugs.